ETF Exchange > PSIL ETF
PSIL - ETF Fact Sheet
AdvisorShares Psychedelics ETF - USD
Fund Identification
Ticker
PSIL
ISIN
US00768Y2972
Main Metrics
Price
$23.08Expense Ratio
1.84%AuM
$43.27MTracking Difference
%Ratings
Trackinsight rating
N/AOfficial Investment Strategy
The AdvisorShares Psychedelics ETF (NYSE ticker: PSIL) invests in the emerging psychedelic drugs sector, offering exposure to those biotechnology, pharmaceutical and life sciences companies we see as leading the way in this nascent industry. Ongoing and growing research has shown various psychedelic substances offering promising medical and therapeutic potential for treating mental health issues and neurological disorders. PSIL concentrates its portfolio on companies deriving the majority of their net revenue or devoting the majority of their assets to psychedelic drugs.
PSIL's historical prices, performance, and flows
1m returns
6.26%
1m flows
$4M
* Net total returns
All data as of 2 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all PSIL data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
PSIL's characteristics
Manager
Manager statistics
17 funds, $1.85Bn in AUM
Asset class
Equity
Dividend policy
Distributing
PSIL's exposure
The PSIL ETF is actively managed, so it doesn't track an index. We're working to retrieve all detailed holding information.
